Found 10 matching trials
A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis
PHASE1This is a randomized, placebo-controlled, ascending single dose study of KH...
Location
Multiple Locations
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
PHASE3To evaluate the efficacy and safety of KHK4827 in patients with systemic sc...
A Phase 3 Clinical Study of KHK4827
PHASE3This study is designed to evaluate safety and efficacy of long-term exposur...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
A Study of KHK4827 in Patients With Systemic Sclerosis
PHASE1Exploratory evaluation of pharmacokinetics and safety of KHK4827 in subject...
Location
The University of Tokyo Hospital
A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
PHASE3The primary objective of this study is to evaluate the efficacy and safety ...
Location
Korea, Republic of
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
PHASE3This study is an open-label, non-controlled study to evaluate the efficacy ...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
A Phase 3 Clinical Study of KHK 4827
PHASE3This study is designed to evaluate the safety and efficacy of long-term exp...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Kirin
A Study of KHK4827 in Subjects With Palmoplantar Pustulosis
PHASE3Evaluation of efficacy and safety of KHK4827 in Subjects with Palmoplantar ...
Location
Takagi Dermatology clinic
A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis
PHASE4The objective of this study is assessing the efficacy and safety of brodalu...
A Phase 2 Clinical Study of KHK4827
PHASE2This study is designed to evaluate the efficacy and safety of KHK4827 in su...
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin